Search This Blog

Thursday, October 31, 2019

bluebird bio EPS misses by $0.19, misses on revenue

bluebird bio (NASDAQ:BLUE): Q3 GAAP EPS of -$3.73 misses by $0.19.
Revenue of $8.91M (-22.7% Y/Y) misses by $3.56M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)